ATI-045 for eczema

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 May 2025: Trial started, NCT07011706
  2. 10 Jun 2025: Trial registered, NCT07011706

The trials

NCT07011706: ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

State
Under way
Phase
Phase 2
People
110 taking part
Started
30 May 2025
Primary completion
21 Sep 2026
Arms
ATI-045 group
Results
None posted
  1. 30 May 2025: Trial started
  2. 10 Jun 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.